The Latest
-
How Goldman Sachs just succinctly told people to start selling their overvalued stocks
-
Fed Is Getting Awfully Close to Backing Apple Stock
-
Mylan to launch generic remdesivir version in India at $64 per 100 mg vial
-
Musk mocks Tesla skeptics with satin shorts